UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

Leukemia, 2013-07, Vol.27 (7), p.1538-1547

2013

Volltextzugriff (PDF)

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)

Bone marrow transplantation (Basingstoke), 2005-12, Vol.36 (11), p.1001-1008

2005

Volltextzugriff (PDF)

The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia

Leukemia, 2016-04, Vol.30 (4), p.800-811

2016

Volltextzugriff (PDF)

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-06, Vol.39 (11), p.677-686

2007

Volltextzugriff (PDF)

Long-term remission in a child with refractory EBV hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Bone marrow transplantation (Basingstoke), 2011-05, Vol.46 (5), p.759-761

2011

Volltextzugriff (PDF)

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab

Bone marrow transplantation (Basingstoke), 2005-11, Vol.36 (9), p.797-802

2005

Volltextzugriff (PDF)

Latent cytomegalovirus infection enhances anti‐tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans

Clinical and experimental immunology, 2016-08, Vol.185 (2), p.239-251

2016

Volltextzugriff (PDF)

T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?

Bone marrow transplantation (Basingstoke), 2007-07, Vol.40 (2), p.93-104

2007

Volltextzugriff (PDF)

T-Cell Immunotherapy for Adenoviral Infections of Stem-Cell Transplant Recipients

Annals of the New York Academy of Sciences, 2005-12, Vol.1062 (1), p.104-115

2005

Volltextzugriff (PDF)

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

The New England journal of medicine, 2020-06, Vol.382 (23), p.2207-2219

2020

Volltextzugriff (PDF)

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

Clinical and experimental immunology, 2013-10, Vol.174 (1), p.89-96

2013

Volltextzugriff (PDF)

The use of central venous catheters (portacaths) in children with Haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2000-03, Vol.6 (2), p.66-70

2000

Volltextzugriff (PDF)

Pediatric Hodgkin Lymphoma: Are We Over-scanning Our Patients?

Pediatric hematology and oncology, 2012-08, Vol.29 (5), p.415-423

2012

Volltextzugriff (PDF)

Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

International journal of cancer, 2001-10, Vol.94 (2), p.228-236

2001

Volltextzugriff (PDF)

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution

Leukemia & lymphoma, 2010-04, Vol.51 (4), p.664-670

2010

Volltextzugriff (PDF)

T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect

Haematologica (Roma), 2015-06, Vol.100 (6), p.709-719

2015

Volltextzugriff (PDF)

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

Cancer gene therapy, 2004-02, Vol.11 (2), p.81-91

2004

Volltextzugriff (PDF)

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

Journal of immunotherapy (1997), 2004-07, Vol.27 (4), p.317-327

2004

Volltextzugriff (PDF)

Options for T-cell based therapies

Vox sanguinis, 2004-07, Vol.87 (s2), p.230-234

2004

Volltextzugriff (PDF)

Immune therapy for EBV infections after hemopoietic stem-cell transplant

Cytotherapy (Oxford, England), 2002-09, Vol.4 (5), p.433-434

2002

Volltextzugriff (PDF)

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

Journal of immunotherapy (1997), 2012-02, Vol.35 (2), p.159-168

2012

Volltextzugriff (PDF)

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Blood, 2005-03, Vol.105 (5), p.1898-1904

2005

Volltextzugriff (PDF)

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

The Journal of experimental medicine, 2004-12, Vol.200 (12), p.1623-1633

2004

Volltextzugriff (PDF)

Targeted immunotherapy for Epstein-Barr virus: Positive central nervous system lymphoma in immunosuppressed patients

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e12529-e12529

2010

Volltextzugriff (PDF)

The TGF-[beta]/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia

Leukemia, 2016-04, Vol.30 (4), p.800

2016

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(239)
Mit Volltextzugriff
(238)

Publikationsform

Sprache

Englisch
(252)
Französisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cytotherapy
(33)
Blood
(15)
Bone Marrow Transplantation
(13)
Journal Of Immunotherapy
(13)
Biology Of Blood And Marrow Transplantation
(12)
Journal Of Clinical Oncology
(10)
Chemical Research In Toxicology
(7)
Xenobiotica
(5)
Analytical Biochemistry
(4)
Blood Advances
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)

The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

Long-term remission in a child with refractory EBV hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab

Latent cytomegalovirus infection enhances anti‐tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans

T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?

T-Cell Immunotherapy for Adenoviral Infections of Stem-Cell Transplant Recipients

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

The use of central venous catheters (portacaths) in children with Haemophilia

Pediatric Hodgkin Lymphoma: Are We Over-scanning Our Patients?

Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution

T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

Options for T-cell based therapies

Immune therapy for EBV infections after hemopoietic stem-cell transplant

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

Targeted immunotherapy for Epstein-Barr virus: Positive central nervous system lymphoma in immunosuppressed patients

The TGF-[beta]/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia

Suchergebnisse filtern